Age-related increase in estrogen may cause common men's hernia

The study, led by Dr. Serdar Bulun, chair and the John J. Sciarra Professor of Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine, found the lower abdominal muscles of mouse models are particularly sensitive to estrogen, developing scar tissue in response to increases in estrogen levels that weakens the abdominal wall and eventually causes a hernia.

When the investigators reduced estrogen with a drug compound, it prevented the hernias, suggesting a therapy with preventive potential in humans.

"It may make sense to treat at-risk men with an aromatase inhibitor that could decrease estrogen and strengthen the muscle," said Bulun, also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Inguinal hernias occur when tissue, such as the intestines, protrudes through the inguinal canal, a weak spot near the groin in the human abdominal wall. These hernias are the most common reason men undergo surgery. There are more than 700,000 inguinal hernia repair surgeries performed each year in the United States, according to the Food and Drug Administration. While the chances of an inguinal hernia increase as men age, the root cause remains unknown.

One other consequence of aging in men is that a larger share of testosterone is converted to estrogen by a hormone called aromatase.

Bulun, whose chief scientific interests include breast cancer and gynecology, was investigating the effects of high estrogen in female mice. One experiment involved boosting estrogen levels by incorporating the human aromatase gene into the mouse genome, creating mice who would convert testosterone into estrogen throughout the body. Originally, he wasn't even interested in the male mice -- until an animal keeper at Northwestern spotted large hernias developing in only the males.

Bulun investigated these mice, finding large swaths of fibroblasts -- scar tissue -- developing in a small muscular sphincter, a structure analogous to the inguinal canal in humans.

"We realized the lower abdominal muscle is extraordinarily sensitive to estrogen," Bulun said. "Estrogen causes these fibroblasts to divide rapidly, at a much higher pace than the muscle cells."

The proliferation of the fibroblasts weakens the integrity of the sphincter and it eventually gives way, causing a hernia. When the investigators gave the mice a drug that blocked aromatase, and therefore the conversion of testosterone to estrogen, the hernias stopped, pointing toward estrogen as the cause and indicating potential for an aromatase inhibitor therapy that may be able to prevent surgery in at-risk patients, Bulun said.

Those patients with greater risk of hernia often have common factors like age or genetics, but overall, Bulun said the best predictor of a future inguinal hernia is a previous one.

"If you have to repair a hernia for the second time, the chances of success go down," Bulun said. "If there is a recurrent case, you might be able to supplement the surgical treatment of that patient with medication."

Bulun is currently working with Dr. Jonah Stulberg, assistant professor of surgery at Feinberg and co-author of the current study, to design clinical trials that would test an aromatase inhibitor's effectiveness in human subjects.

The first author of the paper was Dr. Hong Zhao, research associate professor of obstetrics and gynecology. Other Northwestern authors include Robert Chatterton, professor emeritus of obstetrics and gynecology, and Dr. Warren Tourtellotte, adjunct professor of pathology, all at Feinberg.

This study was supported by grant R37-HD36891 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.